An internationally recognized testing institution, assisting enterprises in achieving technological advancement.
ZHONGXI Testing has obtained inspection qualification certifications from multiple countries and regions worldwide. We possess a senior testing team and advanced testing methods, providing independent, impartial, and professional third-party verification services for global carbon projects.
Certified by multiple international standards such as CNAS, VCS, and GS, with reports universally applicable worldwide.
Covering 140+ countries and regions, it supports on-site detection and remote verification in multiple languages.
Adopt standard experimental methods to ensure accurate and reliable data.
Salvia miltiorrhiza (Danshen) is a cornerstone of traditional Chinese medicine, widely used for its cardiovascular, anti-inflammatory, and neuroprotective effects. Its therapeutic efficacy is primarily attributed to a group of lipophilic abietane-type diterpene quinones—collectively known as tanshinones—with the major bioactive constituents being tanshinone IIA, tanshinone I, cryptotanshinone, and dihydrotanshinone I. The accurate and reliable determination of these compounds is essential for raw material authentication, extract standardization, batch-to-batch consistency, formulation quality assurance, and pharmacokinetic studies. However, tanshinone analysis presents considerable challenges: the compounds are photolabile, susceptible to oxidative degradation, and present in complex matrices with varying polarity; moreover, the existence of numerous structurally similar analogues and isomerisation products demands high-resolution separation and sensitive detection. Our specialized detection platform offers a fully validated suite of chromatographic and mass spectrometric methods, including UHPLC-UV/PDA, UHPLC-MS/MS, and high-resolution LC-QTOF-MS, delivering unparalleled sensitivity, specificity, and structural confirmation. Whether the client is a herbal extract manufacturer, a pharmaceutical company, a contract testing laboratory, or a research institution, our service provides the precise, regulatory-compliant data required to ensure product quality, efficacy, and safety.

Clients seeking tanshinone quantification services are motivated by multiple critical imperatives. In phytopharmaceutical manufacturing, the primary need is to verify that each batch of raw root material, extract, or finished product meets the minimum or designated content of the four major tanshinones as per pharmacopoeial standards (e.g., Chinese Pharmacopoeia, USP, EP), ensuring consistency of bioactivity. In quality assurance and supply chain control, monitoring tanshinone levels helps detect adulteration, improper harvesting, or degradation during storage. In formulation development and stability studies, detailed degradation profiling of individual tanshinones under various stress conditions (heat, light, humidity) is crucial to establishing shelf-life and proper packaging. In pharmacokinetic and pharmacodynamic research, ultra-sensitive detection of tanshinones in biological matrices (plasma, tissues, urine) is required to evaluate bioavailability, tissue distribution, and metabolic pathways. In regulatory submissions, comprehensive analytical data and full method validation per ICH guidelines are mandatory for marketing approvals. Our service is architected to address these diverse needs through a modular, ISO 17025-accredited analytical framework that combines robust quantitative assays with expert interpretive support.
Our analytical platform consists of three interconnected modules that deliver comprehensive tanshinone characterization. The Extraction and Sample Preparation Module employs optimized ultrasonic-assisted extraction with solvent systems (e.g., methanol/water or ethanol) tailored to the sample matrix—whether root powder, dried extract, granule, tablet, or liquid formulation. We incorporate internal standard (e.g., tanshinone IIA-d4 or benzo[a]pyrene) correction to compensate for extraction efficiency and matrix effects, consistently achieving recoveries of 95–103% for all major tanshinones with relative standard deviations < 3%. The Chromatographic Separation Module uses ultra-high-performance liquid chromatography (UHPLC) with a C18 reversed-phase column (1.8 µm, 100 mm), employing a gradient mobile phase of water/acetonitrile (with 0.1% formic acid or phosphoric acid) that achieves baseline separation of tanshinone IIA, tanshinone I, cryptotanshinone, dihydrotanshinone I, as well as minor analogues such as tanshinone IIB, methyl tanshinonate, and przewaquinone A, within a run time of 12 minutes. The Detection and Quantification Module offers dual detection: photodiode array (PDA) at 254 nm and 270 nm for routine quantification, providing LOQs of 0.05–0.1 µg/mL and linearity R² > 0.999 over a range of 0.2–50 µg/mL. For higher sensitivity and specificity, we employ tandem mass spectrometry (UHPLC-MS/MS) in multiple reaction monitoring (MRM) mode, monitoring transitions for tanshinone IIA (m/z 295→249, 277), tanshinone I (m/z 277→249, 233), cryptotanshinone (m/z 297→251, 279), and dihydrotanshinone I (m/z 279→233, 251), achieving LOQs in the low ng/mL range (0.1–0.5 ng/mL) in plant extracts and sub-ng/mL levels in plasma. For unambiguous identification of unknown peaks and impurities, we use high-resolution quadrupole time-of-flight (QTOF) MS with full-scan and data-dependent MS/MS, providing mass accuracy < 2 ppm and molecular formula confirmation. All methods are validated according to ICH Q2(R1) for specificity, linearity, accuracy, precision, LOD, LOQ, range, and robustness, and we provide full validation dossiers upon request.
Our platform consistently delivers superior performance metrics. The UHPLC-PDA method resolves all four major tanshinones with peak resolution Rs > 2.0 and symmetry factors between 0.95 and 1.05. The MRM method exhibits signal-to-noise ratios > 1000:1 at LOQ levels, and our calibration curves show residual errors < 3%. For comprehensive fingerprinting, our QTOF-MS enables the detection and tentative identification of more than 30 tanshinone-related compounds in a single run, providing a chemical barcode for authenticity verification. We also perform forced degradation studies under ICH conditions (acid, base, oxidation, light, heat) with time-course monitoring, enabling the identification of major degradation products (e.g., tanshinone IIA to tanshinone IIA epoxide or hydroxytanshinones). Additionally, we offer chiral separation for optically active tanshinone derivatives when required, using chiral stationary phases. Our integrated data analysis allows for the calculation of fingerprint similarity indices (using the Chinese Pharmacopoeia or other reference standards) and multivariate analysis (PCA, HCA) to assess batch clustering and detect outliers. This depth of characterization ensures that our clients receive not only concentration values but also a full understanding of their sample's chemical integrity.
Our service offers several unique benefits that deliver exceptional value. First, we have developed matrix-specific validated protocols for a wide range of sample types—including crude roots, sliced herbs, powdered extracts, granulated formulations, softgels, tablets, and biological fluids—each optimized for extraction efficiency, clean-up, and minimal matrix interference. Second, we maintain a comprehensive reference standard library containing all major and minor tanshinones, as well as their oxidation and isomerisation products, enabling definitive identification and accurate quantification of even trace components. Third, we provide a rapid screening service using HPTLC-densitometry or UV spectrophotometric multi-component analysis (with chemometric calibration) that yields semi-quantitative tanshinone profiles within 2 hours of sample receipt, ideal for incoming material qualification and rapid process checks. Fourth, our stability-indicating assay packages include comprehensive forced degradation studies, from which we derive degradation kinetics (order, rate constants) and predict shelf-life using Arrhenius modeling—critical for regulatory submissions. Fifth, we offer custom method development and validation for novel tanshinone analogues or unusual matrices, with full documentation and transfer protocols. Sixth, all our methods are accredited under ISO/IEC 17025 and align with Chinese Pharmacopoeia, USP, and EP standards; we provide certificates of analysis (CoA) that meet GMP requirements for raw materials and finished products. Our team includes phytochemical experts and analytical chemists who provide consultative interpretation, helping clients to understand how tanshinone ratios (e.g., tanshinone IIA/tanshinone I) may relate to cultivation conditions, harvest time, or processing parameters.
Our reporting philosophy transforms analytical data into strategic intelligence. We provide a comprehensive final report that includes: (i) a one-page certificate of analysis summarizing the concentration of all quantitated tanshinones, total tanshinone content, and relevant ratios (e.g., IIA/I, cryptotanshinone/dihydrotanshinone), with pass/fail indicators based on client-specific specifications; (ii) a detailed analytical section containing UHPLC and/or MS chromatograms, spectra, calibration curves, system suitability results, and internal standard recoveries; (iii) a fingerprint overlay comparing the sample profile to a reference standard (e.g., pharmacopoeial reference material) with a similarity index; (iv) a stability summary with degradation curves and shelf-life projection, where applicable; and (v) a statistical analysis for multiple batches, including mean, SD, and trend charts. For R&D clients, we provide multivariate correlation with bioactivity data (if provided) to help identify the most active tanshinone components. We also offer customized data exports in Excel, CSV, and PDF formats. Our commitment to transparency includes providing all raw data files and instrument methods, enabling full data auditability.
The versatility of our tanshinone analysis service makes it essential across the entire value chain. In herbal extract manufacturing, our quality control testing supports incoming raw material grading, in-process control during extraction, and final product release. In pharmaceutical formulation development, our stability studies guide the choice of excipients and packaging. In contract manufacturing and testing, our third-party verification provides independent quality assurance. In regulatory compliance, our validated data packages support submissions for novel dietary ingredients, botanical drugs, and traditional medicine registrations. In pharmacological and clinical research, our bioanalytical methods enable PK/PD modeling and bioavailability comparisons across different formulations. In forensic and authenticity testing, our high-resolution fingerprinting can distinguish geographical origins and detect adulteration. Our ability to adapt the analytical approach to the client's specific needs—from simple four-marker quantification to comprehensive metabolic profiling—ensures that we serve a diverse global clientele.
We are continuously enhancing our tanshinone analytical capabilities through R&D. Our current projects include the development of rapid near-infrared (NIR) spectroscopic methods with chemometric calibration for non-destructive, real-time tanshinone prediction in dried roots, and the application of supercritical fluid chromatography (SFC) for faster, greener separations. We actively participate in international proficiency testing for botanical quality parameters and contribute to the development of reference standards and pharmacopoeial monographs. Our quality system is ISO 17025 and ISO 9001 certified, and we follow GMP for all GxP-compliant studies. We offer flexible engagement models, from one-off sample analysis to long-term stability monitoring programs with volume discounts, dedicated project managers, and priority handling. Our global logistics ensure appropriate sample shipping conditions (amber vials, desiccation, temperature control) to prevent tanshinone degradation. Turnaround times are typically 3–5 business days for standard quantitative analysis and 7–12 business days for comprehensive packages including stability or method validation. We maintain open and transparent communication, providing regular progress updates and expert guidance. Ultimately, our success is measured by our clients' ability to meet their quality, safety, and regulatory goals. We invite you to partner with us to ensure the integrity and efficacy of your Danshen products.
In summary, our tanshinone quantification and profiling service delivers a comprehensive, precise, and regulatory-compliant analytical solution that integrates state-of-the-art chromatography and mass spectrometry, robust method validation, and expert interpretive support. By providing deep chemical insights and reliable quantitative data, we empower our clients to optimise quality control, accelerate development, and confidently navigate regulatory pathways. We look forward to supporting your tanshinone analysis needs with our dedicated expertise and cutting-edge capabilities.